Cholangiopathies (Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC)) are characterized by the proliferation/loss of cholangiocytes, which are the cells that line the biliary epithelium. During cholestasis, biliary hyperplasia/damage is regulated by both autocrine/paracrine mechanisms. For example, during hyperplastic cholangiocyte proliferation bile duct mass increases and proliferating cholangiocytes release numerous factors like histamine presumably to sustain the increased bile duct mass. In ductopenic states, bile duct mass decreases and cholangiocytes are damaged and unable to maintain biliary homeostasis. We have shown that: (i) cholangiocytes express histamine receptors (HRs) and histidine decarboxylase (HDC), the key enzyme regulating histamine synthesis; (ii) cholangiocytes release histamine; and (iii) inhibition of biliry HDC decreases both hyperplastic and neoplastic cholangiocyte growth and vascular endothelial growth factor (VEGF) by autocrine pathways. Besides the autocrine regulation of cholangiocyte proliferation/loss, paracrine regulation of biliary function by neighboring hepatic cells must be considered. It has been demonstrated in patients with PBC and PSC that histamine plasma levels are higher and that there are increased numbers of hepatic mast cells in the proximity of bile ducts. When activated, hepatic mast cells release numerous factors like histamine into the microenvironment, which we propose influence cholangiocyte proliferative/apoptotic responses in cholangiopathies. In our proposal, we present preliminary data supporting the hypothesis that mast cells infiltrate the liver following damage via c-kit/SCF interaction and that mast cells alte the proliferative response of small and large cholangiocytes in models of liver damage or repair by interaction with H1 and H2 HRs and specific microRNAs. Our proposed studies are innovative and will likely provide important, clinically relevant data to add to the understanding f the regulation of biliary disorders and also offer insight into novel treatment strategies.

Public Health Relevance

Cholangiopathies are characterized by the proliferation or damage of cholangiocytes. Hepatic mast cell number and histamine levels increase during liver damage and may influence cholangiocyte proliferation. Patient treatments are limited and there is a need for the development of novel treatment strategies.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Sherker, Averell H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Texas A&M University
Internal Medicine/Medicine
Schools of Medicine
College Station
United States
Zip Code
Kennedy, Indsey; Francis, Heather; Meng, Fanyin et al. (2017) Diagnostic and therapeutic potentials of microRNAs in cholangiopathies. Liver Res 1:34-41
Kennedy, Lindsey; Francis, Heather (2017) Defining the relationship between farsenoid X receptor, hepatitis B virus X protein and hepatocellular carcinoma: It's complicated. Hepatology 65:774-776
Francis, Heather; Kennedy, Lindsey; Alpini, Gianfranco (2017) Dual ablation of ?- and ?-catenin: Critical regulators of junctions and their functions. Hepatology :
Wan, Ying; McDaniel, Kelly; Wu, Nan et al. (2017) Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury. Am J Pathol 187:2788-2798
Hargrove, Laura; Kennedy, Lindsey; Demieville, Jennifer et al. (2017) Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice. Hepatology 65:1991-2004
Stephenson, Kristen; Kennedy, Lindsey; Hargrove, Laura et al. (2017) Updates on Dietary Models of Non-Alcoholic Fatty Liver Disease: Current Studies and Insights. Gene Expr :
Kyritsi, Konstantina; Meng, Fanyin; Zhou, Tianhao et al. (2017) Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b. Am J Pathol 187:1551-1565
McDaniel, Kelly; Meng, Fanyin; Wu, Nan et al. (2017) Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in miceā€”. Hepatology 65:544-559
McDaniel, Kelly; Huang, Li; Sato, Keisaku et al. (2017) The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury. J Biol Chem 292:11336-11347
Wan, Ying; Meng, Fanyin; Wu, Nan et al. (2017) Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells. Hepatology 66:528-541

Showing the most recent 10 out of 15 publications